Literature DB >> 9792393

Increasing Kaposi's sarcoma-associated herpesvirus seroprevalence with age in a highly Kaposi's sarcoma endemic region, Zambia in 1985.

S J Olsen1, Y Chang, P S Moore, R J Biggar, M Melbye.   

Abstract

BACKGROUND: Kaposi's sarcoma (KS)-associated herpesvirus (KSHV) is a newly discovered virus found in all forms of KS. In the United States, KSHV infection appears to be most common amongst individuals at high-risk for KS. Preliminary data from Africa suggest that KSHV infection may be much more common in the general population.
OBJECTIVE: To examine the KSHV seroprevalence and age-specific patterns of infection in an African country with high rates of KS.
DESIGN: Cross-sectional seroprevalence study.
METHODS: Sera were taken for a hospital-based HIV seroprevalence study conducted in August 1985 in Lusaka, Zambia at a time when HIV was just becoming epidemic in this area. A total of 251 sera were randomly sampled and examined for antibodies against latent and lytic antigens to KSHV. KSHV seroprevalence was compared with demographic and clinical variables using chi2 test for linear trend and odds ratios and 95% confidence intervals.
RESULTS: Overall, 58% of persons aged 14-84 years were KSHV-seropositive. KSHV seroprevalence increased linearly with age (P = 0.04) and was inversely related to years of education (P = 0.015). In contrast, HIV infection peaked in those aged 20-29 years and was positively related to years of education (P = 0.01 5). No association between KSHV and gender, marital status, or HIV serostatus was seen.
CONCLUSIONS: KSHV infection was significantly more common in this region of Zambia in 1985 than it currently is in the United States. Our data are consistent with KSHV being well-established in this region prior to 1985 and that continued adult transmission of the virus was occurring. The high seroprevalence in the adolescent age-group and the relatively linear increase in prevalence with age suggest that non-sexual modes of transmission may be important for KSHV transmission in Africa.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9792393     DOI: 10.1097/00002030-199814000-00024

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  32 in total

1.  Lytic replication of Kaposi's sarcoma-associated herpesvirus results in the formation of multiple capsid species: isolation and molecular characterization of A, B, and C capsids from a gammaherpesvirus.

Authors:  K Nealon; W W Newcomb; T R Pray; C S Craik; J C Brown; D H Kedes
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

2.  Human herpesvirus 8 infection in children and adults in a population-based study in rural Uganda.

Authors:  Lisa M Butler; Willy A Were; Steven Balinandi; Robert Downing; Sheila Dollard; Torsten B Neilands; Sundeep Gupta; George W Rutherford; Jonathan Mermin
Journal:  J Infect Dis       Date:  2011-01-26       Impact factor: 5.226

3.  Sex and geographic patterns of human herpesvirus 8 infection in a nationally representative population‐based sample in Uganda.

Authors:  Benon Biryahwaho; Sheila C Dollard; Ruth M Pfeiffer; Fatma M Shebl; Stella Munuo; Minal M Amin; Wolfgang Hladik; Ruth Parsons; Sam M Mbulaiteye
Journal:  J Infect Dis       Date:  2010-11-01       Impact factor: 5.226

Review 4.  The viral etiology of AIDS-associated malignancies.

Authors:  Peter C Angeletti; Luwen Zhang; Charles Wood
Journal:  Adv Pharmacol       Date:  2008

5.  The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor contains an immunoreceptor tyrosine-based inhibitory motif that activates Shp2.

Authors:  Nicola Philpott; Thomas Bakken; Christopher Pennell; Liwei Chen; Jie Wu; Mark Cannon
Journal:  J Virol       Date:  2010-11-03       Impact factor: 5.103

6.  Human herpesvirus 8 seropositivity in rural Uganda: maturation of sero-epidemiological studies.

Authors:  Sam M Mbulaiteye; James J Goedert
Journal:  J Infect Dis       Date:  2011-01-26       Impact factor: 5.226

7.  Clinical presentation and outcome of epidemic Kaposi sarcoma in Ugandan children.

Authors:  Soren Gantt; Abel Kakuru; Anna Wald; Victoria Walusansa; Lawrence Corey; Corey Casper; Jackson Orem
Journal:  Pediatr Blood Cancer       Date:  2010-05       Impact factor: 3.167

Review 8.  HIV and human herpesvirus 8 co-infection across the globe: Systematic review and meta-analysis.

Authors:  Eliane Rohner; Natascha Wyss; Zina Heg; Zully Faralli; Sam M Mbulaiteye; Urban Novak; Marcel Zwahlen; Matthias Egger; Julia Bohlius
Journal:  Int J Cancer       Date:  2015-07-28       Impact factor: 7.396

9.  Non AIDS Kaposi's Sarcoma Leading to Lower Extremities Wounds, Case Presentations and Discussion.

Authors:  Laemthong Phavixay; David Raynolds; Richard Simman
Journal:  J Am Coll Clin Wound Spec       Date:  2013-01-19

10.  EBV, HHV8 and HIV in B cell non Hodgkin lymphoma in Kampala, Uganda.

Authors:  Lynnette K Tumwine; Jackson Orem; Patrick Kerchan; Wilson Byarugaba; Stefano A Pileri
Journal:  Infect Agent Cancer       Date:  2010-06-30       Impact factor: 2.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.